Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like PPD???s Recognized For Industry Leadership August 10, 2017 3 Rock-Bottom Biotechs That Big Market Players are Betting On May 15, 2017 Eiger Biopharma Reports First Quarter 2017 Financial Results May 11, 2017